Epidemiology of Budd–Chiari Syndrome

  • Nicoletta Riva
  • Walter AgenoEmail author


Budd-Chiari syndrome (BCS) is a rare but severe liver disorder, with low incidence and prevalence in the general population. The incidence reported in the literature ranges from 0.2 to 4.1 cases per million inhabitants per year, with an estimated prevalence of 2.4–7.7 per million inhabitants in Asian countries and of 1.4–4.0 per million inhabitants in Western countries. A predominance of females was reported in the West (52–69%), while in Asian studies males were more frequently affected (48–70%). Patients with BCS tend to be younger than patients with splanchnic vein thrombosis in other sites or venous thromboembolism, with wide variability reported in different countries (e.g. Pakistan, Nepal, Egypt mid-twenties vs USA, Australia, Italy and Denmark in the late-40s/early-50s). Finally, prevalence of BCS in patients with different risk factors (such as myeloproliferative neoplasm, paroxysmal nocturnal haemoglobinuria, Behçet’s disease or liver diseases) is highly variable.


Budd-Chiari syndrome Epidemiology Incidence Prevalence Venous thrombosis 


  1. 1.
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64(1):179–202.CrossRefGoogle Scholar
  2. 2.
    Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol. 2007;13(13):1912–27.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12(Suppl 1):168–80.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Li Y, De Stefano V, Li H, Zheng K, Bai Z, Guo X, et al. Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018;43(4):468–74. pii: S2210-7401(18)30230-4 [Epub ahead of print] PubMed PMID: 30528513.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology. 1991;13:650–5.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995;22(1):1–9.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int. 2009;29(2):253–9.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH. Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study. Liver Int. 2016;36(7):1067–73.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost. 2017;117(4):794–800.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis. 2018;50(9):931–7.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, et al. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44(11–12):1152–67.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis. 2011;3(1):e2011063.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, et al. Budd-Chiari syndrome in China: a 30-year retrospective study on survival from a single center. World J Gastroenterol. 2018;24(10):1134–43.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Zhang W, Qi X, Zhang X, Su H, Zhong H, Shi J, et al. Budd-Chiari Syndrome in China: a systematic analysis of epidemiological features based on the Chinese Literature Survey. Gastroenterol Res Pract. 2015;2015:738548.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, et al. Redefining Budd-Chiari syndrome: a systematic review. World J Hepatol. 2016;8(16):691–702.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Derman BA, Kwaan HC. Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis. Semin Thromb Hemost. 2015;41(5):503–13.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010;8(2):200–5.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–75.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol. 2011;54(1):56–63.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol. 2008;14(18):2858–62.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    De BK, De KK, Sen S, Biswas PK, Das TK, Das S, et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India. 2000;48(8):800–3.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11(2):170–9.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Sawant P, Vashishtha C, Nasa M, Parikh P, Patel J, Agasti A. Thrombophilia profile in Budd-Chiari syndrome and Splanchnic Vein Thrombosis: a study from Western India. J Assoc Physicians India. 2015;63(9):32–5.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol. 2010;29(1):8–11.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Parkash O, Khan A, Hamid S. Clinical characteristics and outcome of Budd-Chiari syndrome at a tertiary care hospital in Pakistan. J Coll Physicians Surg Pak. 2017;27(5):301–4.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome. Intern Med J. 2017;47(12):1361–7.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Sakr M, Abdelhakam SM, Dabbous H, Hamed A, Hefny Z, Abdelmoaty W, et al. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome. Liver Int. 2017;37(3):415–22.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, et al. Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol. 2011;17(42):4704–10.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Søgaard KK, Darvalics B, Horváth-Puhó E, Sørensen HT. Survival after splanchnic vein thrombosis: a 20-year nationwide cohort study. Thromb Res. 2016;141:1–7.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Li G, Huang Y, Tang S, Song Y, Liang H, Liu D, et al. A single-center retrospective study: clinical features of different types of Budd-Chiari syndrome in Chinese patients in the Hubei area. Vascular. 2018;26(1):80–9.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Sakr MA, Abdelkader N, Dabbous H, Eldorry A. Prevalence of portal vein thrombosis in Egyptian patients with Budd-Chiari syndrome. Indian J Gastroenterol. 2014;33(5):489–91.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Ageno W, Riva N, Schulman S, Bang SM, Sartori MT, Grandone E, et al. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry. Semin Thromb Hemost. 2014;40(1):99–105.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Riva N, Ageno W, Schulman S, Beyer-Westendorf J, Duce R, Malato A, et al. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. Lancet Haematol. 2016;3(6):e267–75.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Shaikh MS, Shaikh MU, Adil SN, Khurshid M, Ahmed ZA. Clinico-pathological profile and outcomes of patients with polycythaemia vera, essential thrombocythaemia and idiopathic myelofibrosis: a tertiary care center experience from Southern Pakistan. J Ayub Med Coll Abbottabad. 2016;28(2):293–7.PubMedPubMedCentralGoogle Scholar
  35. 35.
    De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, et al. Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. Blood Cancer J. 2016;6(11):e493.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res. 2014;133(6):1052–5.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Van Bijnen ST, Van Heerde WL, Muus P. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost. 2012;10(1):1–10.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Poulou LS, Xila V, Rokas GI, Karianakis G, Bartzoudis D, Ziakas PD. Temporal trends in mortality rates from visceral vein thrombosis in paroxysmal nocturnal haemoglobinuria: an optimistic view. Thromb Haemost. 2008;99(3):642–5.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    AlGhasham N, Abulkhair Y, Khalil S. Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: a single-center experience in Saudi Arabia. Cytometry B Clin Cytom. 2015;88(6):389–94.PubMedCrossRefGoogle Scholar
  40. 40.
    Khan M, Ahmad SQ, Bashir M, Ahmed P, Ayyub M. Clinico-haematological features of paroxysmal nocturnal haemoglobinuria. J Coll Physicians Surg Pak. 2017;27(1):53–4.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behçet’s disease. Gastroenterol Clin Biol. 2008;32(3):316–20.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology. 2014;53(11):2018–22.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Seyahi E, Caglar E, Ugurlu S, Kantarci F, Hamuryudan V, Sonsuz A, et al. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated center. Semin Arthritis Rheum. 2015;44(5):602–9.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, et al. Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease. Arthritis Rheum. 2012;64(8):2753–60.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, et al. Mortality in Behçet’s disease. Arthritis Rheum. 2010;62(9):2806–12.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Zöller B, Li X, Sundquist J, Sundquist K. Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden. J Intern Med. 2011;270(2):158–65.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Karnsakul W, Ingviya T, Seaberg E, Laengvejkal P, Imteyaz H, Vasilescu A, et al. Ascites in children: a single-center experience of 27 years. J Pediatr Gastroenterol Nutr. 2017;64(1):83–8.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Poddar U, Thapa BR, Rao KL, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol. 2008;23(9):1354–7.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Topdagi O, Okcu N, Bilen N. The frequency of complications and the etiology of disease in patients with liver cirrhosis in erzurum. Eurasian J Med. 2014;46(2):110–4.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Aydoğdu S, Ozgenç F, Yurtsever S, Akman SA, Tokat Y, Yağci RV. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J Trop Pediatr. 2003;49(6):367–70.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Adukauskiene D, Dockiene I, Naginiene R, Kevelaitis E, Pundzius J, Kupcinskas L. Acute liver failure in Lithuania. Medicina. 2008;44(7):536–40.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6(3):339–45.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392–8.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Sakamoto S, Egawa H, Kanazawa H, Shibata T, Miyagawa-Hayashino A, Haga H, et al. Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl. 2010;16(10):1207–14.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Krishna Kumar G, Sharif K, Mayer D, Mirza D, Foster K, Kelly D, et al. Hepatic venous outflow obstruction in paediatric liver transplantation. Pediatr Surg Int. 2010;26(4):423–5.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Galloux A, Pace E, Franchi-Abella S, Branchereau S, Gonzales E, Pariente D. Diagnosis, treatment and outcome of hepatic venous outflow obstruction in paediatric liver transplantation: 24-year experience at a single centre. Pediatr Radiol. 2018;48(5):667–79.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of Pathology, Faculty of Medicine and Surgery, University of MaltaMsidaMalta
  2. 2.Department of Medicine and Surgery, University of InsubriaVareseItaly

Personalised recommendations